NASDAQ
Albireo Pharma, Inc. (ALBO) has a free cash flow growth of 19.98% as of Friday, May 29, 2026. This represents a 184.38% increase compared to its 12-month average of -23.68%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.